No Javascript detected!
This website works best with Javascript enabled. Here is some help to get you started -
How to enable Javascript
×
loading
Strategic Report
Welcome to Dechra Pharmaceuticals PLC
Highlights
Group at a Glance
Chairman's and Chief Executive Officer's Statement
Delivering Our Strategy
Strategy in Action
Q&A with Ian Page
Our Business Model
Creating Value
Our Marketplace
Our Key Products
International Footprint
Product Development
Financial Review
Key Performance Indicators
Corporate Social Responsibility
How the Business Manages Risk
Understanding Our Key Risks
Our Governance
Board of Directors
Letter from the Chairman on Governance
Corporate Governance
Letter from the Audit Committee Chairman
Audit Committee Report
Nomination Committee Report
Letter from the Remuneration Committee Chairman
Directors' Remuneration Report
Directors' Report - Other Disclosures
Statement of Directors' Responsibilities
Our Financials
Independent Auditor's Report to the Members of Dechra Pharmaceuticals PLC
Consolidated Income Statement
Consolidated Statement of Comprehensive Income
Consolidated Statement of Financial Position
Consolidated Statement of Changes in Shareholders' Equity
Consolidated Statement of Cash Flows
Notes to the Consolidated Financial Statements
Company Statement of Financial Position
Statement of Changes in Shareholders' Equity
Notes to the Company Financial Statements
Financial History
Company Information
Glossary
Shareholder Information
Advisers
Home
Our Financials
Statement of Changes in Shareholders' Equity
Annual Report & Accounts
for the year ended 30 June 2016
Independent Auditor's Report to the Members of Dechra Pharmaceuticals PLC
Consolidated Income Statement
Consolidated Statement of Comprehensive Income
Consolidated Statement of Financial Position
Consolidated Statement of Changes in Shareholders' Equity
Consolidated Statement of Cash Flows
Notes to the Consolidated Financial Statements
Company Statement of Financial Position
Statement of Changes in Shareholders' Equity
Notes to the Company Financial Statements
Financial History
Statement of Changes in Shareholders' Equity
For the year ended 30 June 2016
Attributable to owners of the parent
Issued
share
capital
£000
Share
premium
account
£000
Hedging
reserve
£000
Foreign
currency
translation
reserve
£000
Retained
earnings
£000
Total
equity
£000
Year ended 30 June 2015
At 1 July 2014
877
124,430
(132)
545
56,095
181,815
Profit for the period
—
—
—
—
42,800
42,800
Effective portion of changes in fair value of cash flow hedges, net of tax
—
—
(137)
—
—
(137)
Losses arising available for sale financial assets
—
—
—
—
(37)
(37)
Cash flow hedges recycled to income statement, net of tax
—
—
178
—
—
178
Total comprehensive income
—
—
41
—
42,763
42,804
Transactions with owners
Dividends paid
—
—
—
—
(13,857)
(13,857)
Share-based payments
—
—
—
—
1,767
1,767
Shares issued
3
371
—
—
—
374
Total contributions by and distributions to owners
3
371
—
—
(12,090)
(11,716)
At 30 June 2015
880
124,801
(91)
545
86,768
212,903
Year ended 30 June 2016
At 1 July 2015
880
124,801
(91)
545
86,768
212,903
Loss for the period
—
—
—
—
(5,772)
(5,772)
Effective portion of changes in fair value of cash flow hedges, net of tax
—
—
(154)
—
—
(154)
Losses arising available for sale financial assets
—
—
—
—
(450)
(450)
Cash flow hedges recycled to income statement, net of tax
—
—
230
—
—
230
Total comprehensive income
—
—
76
—
(6,222)
(6,146)
Transactions with owners
Dividends paid
—
—
—
—
(15,292)
(15,292)
Share-based payments
—
—
—
—
3,536
3,536
Shares issued
47
47,650
—
—
—
47,697
Total contributions by and distributions to owners
47
47,650
—
—
(11,756)
35,941
At 30 June 2016
927
172,451
(15)
545
68,790
242,698
prev
Company Statement of Financial Position
next
Notes to the Company Financial Statements